Home > Financial Ratios > BAFNA PHARMACEUTICALS

BAFNA PHARMACEUTICALS
Fixed Capital/Sales

    Back to All Ratios
COMMUNITY POLL
for BAFNA PHARMACEUTICALS
Please provide your vote to see the results

BAFNA PHARMACEUTICALS Last 5 Year Fixed Capital/Sales History

[Standalone]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Fixed Capital/Sales(x) 0.700.640.790.981.08

What is the latest Fixed Capital/Sales ratio of BAFNA PHARMACEUTICALS ?

The latest Fixed Capital/Sales ratio of BAFNA PHARMACEUTICALS is 0.70 based on Mar2025 Standalone results.
Year Fixed Capital/Sales
Mar20250.70
Mar20240.64
Mar20230.79
Mar20220.98
Mar20211.08

How is Fixed Capital/Sales of BAFNA PHARMACEUTICALS Trending?

Years Fixed Capital/Sales % Change
Mar2025 0.7
9.37
Mar2024 0.64
-18.99
Mar2023 0.79
-19.39
Mar2022 0.98
-9.26
Mar2021 1.08 -

Other Financial Ratios of BAFNA PHARMACEUTICALS


Compare Fixed Capital/Sales ratio of peers of BAFNA PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BAFNA PHARMACEUTICALS ₹288.9 Cr -9.4% -25.9% 35.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹391,488.0 Cr -2.1% -7.7% -9.7% Stock Analytics
DIVIS LABORATORIES ₹159,415.0 Cr -2.6% -6.8% 1.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹132,906.0 Cr 0.1% 5.5% 25.3% Stock Analytics
CIPLA ₹106,210.0 Cr -1.9% -9.3% -5.1% Stock Analytics
DR REDDYS LABORATORIES ₹103,089.0 Cr 3.5% -5.2% -11.8% Stock Analytics


BAFNA PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
BAFNA PHARMACEUTICALS

-9.4%

-25.9%

35.8%

SENSEX

-2.4%

-4.7%

6.4%


You may also like the below Video Courses